| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Onconova Therapeutics Inc (NASDAQ: ONTX)
ONTX Technical Analysis
4
| As on 9th Jun 2023 ONTX STOCK Price closed @ 1.12 and we RECOMMEND Sell for LONG-TERM with Stoploss of 1.40 & Strong Sell for SHORT-TERM with Stoploss of 2.01 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ONTXSTOCK Price
| Open | 1.15 | Change | Price | % |
| High | 1.16 | 1 Day | -0.05 | -4.27 |
| Low | 1.10 | 1 Week | -0.05 | -4.27 |
| Close | 1.12 | 1 Month | -0.05 | -4.27 |
| Volume | 91126 | 1 Year | -1.67 | -59.86 |
| 52 Week High 2.85 | 52 Week Low 0.63 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ONTX Daily Charts |
ONTX Intraday Charts |
Whats New @ Bazaartrend |
ONTX Free Analysis |
|
|
ONTX Important Levels Intraday
| RESISTANCE | 1.24 |
| RESISTANCE | 1.20 |
| RESISTANCE | 1.18 |
| RESISTANCE | 1.15 |
| SUPPORT | 1.09 |
| SUPPORT | 1.06 |
| SUPPORT | 1.04 |
| SUPPORT | 1.00 |
ONTX Forecast May 2024
| 4th UP Forecast | 2.76 |
| 3rd UP Forecast | 2.23 |
| 2nd UP Forecast | 1.91 |
| 1st UP Forecast | 1.58 |
| 1st DOWN Forecast | 0.66 |
| 2nd DOWN Forecast | 0.33 |
| 3rd DOWN Forecast | 0.01 |
| 4th DOWN Forecast | -0.52 |
ONTX Weekly Forecast
| 4th UP Forecast | 1.95 |
| 3rd UP Forecast | 1.68 |
| 2nd UP Forecast | 1.52 |
| 1st UP Forecast | 1.35 |
| 1st DOWN Forecast | 0.89 |
| 2nd DOWN Forecast | 0.72 |
| 3rd DOWN Forecast | 0.56 |
| 4th DOWN Forecast | 0.29 |
ONTX Forecast2024
| 4th UP Forecast | 5.55 |
| 3rd UP Forecast | 4.13 |
| 2nd UP Forecast | 3.25 |
| 1st UP Forecast | 2.37 |
| 1st DOWN Forecast | -0.13 |
| 2nd DOWN Forecast | -1.01 |
| 3rd DOWN Forecast | -1.89 |
| 4th DOWN Forecast | -3.31 |
Onconova Therapeutics Inc ( NASDAQ USA Symbol : ONTX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ONTX Business Profile
Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. The company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation. Its novel proprietary multi-kinase inhibitor ON 123300 to target CDK4/6 and other tyrosine kinases. The company's product candidate oral rigosertib, which is in Phase 1 study of rigosertib in combination with a PD-1 inhibitor for patients with progressive K-Ras mutated non-small cell lung cancer; and in Phase 1b/2 for recessive dystrophic epidermolysis bullosa. In addition, it is involved in preclinical work investigating rigosertib in COVID-19. The company has a license agreement with SymBio Pharmaceuticals Limited; and license, development, and commercialization agreement with Pint International SA. Onconova Therapeutics, Inc. was founded in 1998 and is headquartered in Newtown, Pennsylvania. Address: 375 Pheasant Run, Newtown, PA, United States, 18940
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service